• Email Alerts
  • Careers
  • Contact Us

SCYNEXIS, Inc.

  • Home
  • About Us
    • Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Partnerships
    • Careers
    • Contact
  • Product
    • ibrexafungerp
    • Patent
  • Pipeline
    • Ibrexafungerp Development Pipeline
    • Clinical Trials
    • Vulvovaginal Candidiasis
    • Refractory Invasive Fungal Infections
    • Invasive Candidiasis
    • Invasive Aspergillosis
  • Science
    • SCYNEXIS Research Platform
    • Publications and Presentations
    • Expanded Access
  • News
    • Press Releases
    • Events
  • Investors
    • Overview
    • News Releases
    • Events & Presentations
    • Corporate Governance
    • Financials & Filings
    • Stock Data

SCYNEXIS, Inc.

You are now leaving the SCYNEXIS Corporate Website.

I understand Cancel

Posters and Presentations

Science

Science

  • SCYNEXIS Research Platform
  • Publications and Presentations
  • Expanded Access
  • Publications and Presentations

  • Posters and Presentations
Clear Search
Combination Therapy with SCY-078 and Isavuconazole for Treatment of Experimental Invasive Pulmonary Aspergillosis

Combination Therapy with SCY-078 and Isavuconazole for Treatment of Experimental Invasive Pulmonary Aspergillosis

V. Petraitis, S. Barat, K. Borroto-Esoda, D. Angulo, T. Walsh
AAA 2018
February 2018

SCY-078 Demonstrates Significant Antifungal Activity in a Murine Model of Invasive Aspergillosis

SCY-078 Demonstrates Significant Antifungal Activity in a Murine Model of Invasive Aspergillosis

K. Borroto-Esoda, S. Barat, D. Angulo, C. Carruthers, K. Holden, P. Warn
IDWeek 2017
October 2017

Assessment of the <em>In Vitro</em> Antifungal Activity of SCY-078 Against a Collection of <em>C. parapsilosis</em> Clinical Isolates

Assessment of the In Vitro Antifungal Activity of SCY-078 Against a Collection of C. parapsilosis Clinical Isolates

S. Barat, D. Angulo, K. Borroto-Esoda, M. Ghannoum
IDWeek 2017
October 2017

SCY-078 Demonstrates Significant Tissue Penetration in Rats and Mice Following Oral or IV Administration

SCY-078 Demonstrates Significant Tissue Penetration in Rats and Mice Following Oral or IV Administration

S. Barat, K. Borroto-Esoda, D. Angulo, C. Carruthers
IDWeek 2017
October 2017

The Effect of pH on the <em>In Vitro</em> Antifungal Activity of SCY-078

The Effect of pH on the In Vitro Antifungal Activity of SCY-078

E. Larkin, C. Hager, L. Long, N. Isham, S. Barat, K. Borroto-Esoda, S. Wring, D. Angulo, M. Ghannoum
IDSOG 2017
August 2017

Vaginal Concentrations of SCY-078, a Novel Glucan Synthase Inhibitor, Following Oral Administration in Mice

Vaginal Concentrations of SCY-078, a Novel Glucan Synthase Inhibitor, Following Oral Administration in Mice

S. Barat, K. Borroto-Esoda, S. Wring, D. Angulo
IDSOG 2017
August 2017

Assessment of the <em>In Vitro</em> Antifungal Activity of SCY-078 Against a Panel of Susceptible and Resistant, Clinical <em>Candida</em> Isolates from Europe

Assessment of the In Vitro Antifungal Activity of SCY-078 Against a Panel of Susceptible and Resistant, Clinical Candida Isolates from Europe

K. Borroto-Esoda, S. Birchall, C. B. Moore, D. Angulo
ASM Microbe 2017
June 2017

Lack of an Effect of SCY-078, a Novel Antifungal Agent on QTc Interval in Healthy Subjects

Lack of an Effect of SCY-078, a Novel Antifungal Agent on QTc Interval in Healthy Subjects

G. Murphy, B. Darpo, T. Marbury, M. Hyman, D. Angulo
ASM Microbe 2017
June 2017

<em>In vitro</em> Interaction between SCY-078, Echinocandins and Azoles against Susceptible & Resistant <em>Candida</em> spp. Determined by the Checkerboard Method

In vitro Interaction between SCY-078, Echinocandins and Azoles against Susceptible & Resistant Candida spp. Determined by the Checkerboard Method

K. Borroto-Esoda, B. Scorneaux, D. Angulo, S. Helou
ASM Microbe
June 2017

Evaluation of Antifungal Activity of SCY-078 in Combination with Other Antifungals Against <em>Aspergillus</em> Strains

Evaluation of Antifungal Activity of SCY-078 in Combination with Other Antifungals Against Aspergillus Strains

L. Long, E. Larkin, K. Borroto-Esoda, S. Wring, D. Angulo, M. Ghannoum
27th European Congress of Clinical Microbiology and Infectious Diseases
April 2017

  • « Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next »

1 Evertrust Plaza, Jersey City, NJ 07302
(201) 884-5485
View Google Map

© 2022 SCYNEXIS, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap Contact Us